Managing class imbalance and differential staining of immune cell populations in multi-class instance segmentation of multiplexed immunofluorescence images of Lupus Nephritis biopsies
暂无分享,去创建一个
Maryellen L. Giger | Madeleine S. Durkee | Marcus R. Clark | Rebecca Abraham | Junting Ai | M. Giger | M. Clark | Junting Ai | R. Abraham
[1] Ross B. Girshick,et al. Mask R-CNN , 2017, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[2] Nir Hacohen,et al. The immune cell landscape in kidneys of patients with lupus nephritis , 2019, Nature Immunology.
[3] Jennifer C. Waters,et al. Accuracy and precision in quantitative fluorescence microscopy , 2009, The Journal of cell biology.
[4] Maryellen L. Giger,et al. Quantifying in situ adaptive immune cell cognate interactions in humans , 2019, Nature Immunology.
[5] F. Silvestris,et al. The Interplay of Chemokines and Dendritic Cells in the Pathogenesis of Lupus Nephritis , 2005, Annals of the New York Academy of Sciences.
[6] T. Utset,et al. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring , 2011, Arthritis care & research.
[7] M. Ward,et al. Risk of End‐Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015: A Systematic Review and Bayesian Meta‐Analysis , 2016, Arthritis & rheumatology.
[8] Maryellen L. Giger,et al. Quantifying the effects of biopsy fixation and staining panel design on automatic instance segmentation of immune cells in human lupus nephritis , 2021, Journal of biomedical optics.
[9] C. Gordon,et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. , 2010, Arthritis and rheumatism.
[10] K. Kalunian,et al. Sifalimumab, a Human Anti–Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose-Escalation Study , 2013, Arthritis and rheumatism.